Publications

Publication Search

Search for publications by

B cells as effectors and regulators of autoimmunity

Abstract

A classic understanding of the interplay between B and T cell components of the immune system that drive autoimmunity, where B cells provide an effector function, is represented by systemic lupus erythematosus (SLE), an autoimmune condition characterised by the production of auto-antibodies. In SLE, CD4+T cells provide cognate help to self-reactive B cells, which in turn produce pathogenic auto-antibodies (1). Thus, B cells act as effectors by producing auto-antibody aided by T cell help such that B and T cell interactions are unidirectional. However, this paradigm of B and T cell interactions is challenged by new clinical data demonstrating that B cell depletion is effective for T cell mediated autoimmune diseases including type I diabetes mellitus (T1D) (2), rheumatoid arthritis (3), and multiple sclerosis (4). These clinical data indicate a model whereby B cells can influence the developing autoimmune T cell response, and therefore act as effectors, in ways that extend beyond the production of autoantibody (5). In this review by largely focusing on type I diabetes we will develop a hypothesis that bi-directional B and T interactions control the course of autoimmunity.

Type Journal
Authors Marino, E.; Grey, S. T.
Garvan Authors A/Prof Shane Grey
Publisher Name AUTOIMMUNITY
Published Date 2012-08-01 00:00:00
Published Volume 45
Published Issue 5
Published Pages 377-87
URL http://www.ncbi.nlm.nih.gov/pubmed/22432804
Status Published In-print
OpenAccess Link https://publications.gimr.garvan.org.au/download.php?11340_11912/12 Marino Autoimmunity_.pdf